BillionToOne BLLN
NASDAQ BLLN
$95.29 -0.93 (-0.97%)
As of: Aug 27, 2026 · 3:59 PM EDT

BillionToOne (BLLN) Notes Payables (2025 - 2026)

BillionToOne (BLLN) posted Notes Payables of $8.9 million for Q1 2026, down 3.86% sequentially from $9.3 million in Q4 2025.

BillionToOne (BLLN) Notes Payables (2025 - 2026) Analysis & Trends

BillionToOne has reported Notes Payables for 2 years, with the latest figure at $8.9 million in Q1 2026.

  • Quarterly Notes Payables changed N/A year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (changed N/A YoY) and the FY2025 annual result came in at $9.3 million, changed N/A from the prior year.
  • Notes Payables retreated to $8.9 million in Q1 2026 per BLLN's latest filing, from $9.3 million in the prior quarter.
  • Over five years, Notes Payables peaked at $9.3 million in Q4 2025 and troughed at $8.9 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn
10 BillionToOne 4.42 Bn 3.87 Bn 77.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 8.92 Mn
Dec 31, 2025 9.28 Mn